Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	View
JYSB2101173	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-11-29		Lilly France		view
JYSZ2300006	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14				view
AS19990014	重组人胰岛素注射液	human insulin	Injection	Biological Products	Import Drug Application	2000-01-01	赫司特（中国）投资有限公司		Approval Completed-Pending Certificated	view
JYSZ2200014	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2022-04-14				view
JYSZ2100525	精蛋白人胰岛素混合注射液(50R)	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-07-24				view
CYSB2300234	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-12-21		Gan & Lee Pharmaceuticals		view
H20010269	生物合成人胰岛素注射液	biosynthetic human insulin	Injection	Chemical Drugs	Import Drug Application	2001-11-12	诺和诺德（天津）生物技术有限公司	Novo Nordisk (China) Pharmaceuticals Co Ltd	Approval Completed-Pending Certificated	view
JYSZ2100517	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2021-05-14				view
JYSZ2200061	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-11-08				view
JYSZ2200013	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2022-03-11				view
JYSZ2200026	精蛋白人胰岛素混合注射液(30R)	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2022-06-24				view
JYSZ2100516	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	License Renew	2021-05-12				view
CYSB2200246	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2022-10-12		Hefei Tianmai BIOTECHNOLOGY Development Co Ltd		view
JYSZ2300007	人胰岛素注射液	human insulin	Injection	Biological Products	License Renew	2023-02-14				view
CYSB2101093	精蛋白人胰岛素混合注射液（40R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-06-17		Tonghua Dongbao Pharmaceutical Co Ltd		view
JYSZ2100511	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	License Renew	2021-04-23				view
CYSB2300203	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-11-03		Novo Nordisk (China) Pharmaceuticals Co Ltd		view
CYSB2101283	人胰岛素注射液	human insulin	Injection	Biological Products	Supplementary Application	2021-12-10		Novo Nordisk (China) Pharmaceuticals Co Ltd		view
CYSB2101285	精蛋白人胰岛素混合注射液（50R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2021-12-10		Novo Nordisk (China) Pharmaceuticals Co Ltd		view
JYSB2101187	精蛋白人胰岛素注射液	Isophane Protamine Human Insulin	Injection	Biological Products	Supplementary Application	2021-12-09		Lilly France		view